Abstract:Background: Inflammatory bowel disease (IBD) is a multifactorial chronic inflammatory disease resulting from dysregulation of the mucosal immune response and gut microbiota. Crohn's disease (CD) and ulcerative colitis (UC) are difficult to distinguish, and differential diagnosis is essential for establishing a long-term treatment plan for patients. Furthermore, the abundance of mucosal bacteria is associated with the severity of the disease. This study aimed to differentiate and diagnose these two diseases using the microbiome and identify specific biomarkers associated with disease activity. Results: Differences in the abundance and composition of the microbiome between IBD patients and healthy controls (HC) were observed. Compared to HC, the diversity of the gut microbiome in patients with IBD decreased; the diversity of the gut microbiome in patients with CD was significantly lower. Sixty-eight microbiota members (28 for CD and 40 for UC) associated with these diseases were identified. Additionally, as the disease progressed through different stages, the diversity of the bacteria decreased. The abundances of Alistipes shahii and Pseudodesulfovibrio aespoeensis were negatively correlated with the severity of CD, whereas the abundance of Polynucleobacter wianus was positively correlated. The severity of UC was negatively correlated with the abundance of A. shahii, Porphyromonas asaccharolytica and Akkermansia muciniphilla, while it was positively correlated with the abundance of Pantoea candidatus pantoea carbekii. A regularized logistic regression model was used for the differential diagnosis of the two diseases. The area under the curve (AUC) was used to examine the performance of the model. The model discriminated UC and CD at an AUC of 0.873 (train set), 0.778 (test set), and 0.633 (validation set) and an area under the precision-recall curve (PRAUC) of 0.888 (train set), 0.806 (test set), and 0.474 (validation set). Conclusions: Based on fecal whole-metagenome shotgun (WMS) sequencing, CD and UC were diagnosed using a machine-learning predictive model. Microbiome biomarkers associated with disease activity (UC and CD) are also proposed.

The microbiome can predict mucosal healing in small intestine in patients with Crohn’s disease

The microbiome can predict mucosal healing in small intestine in patients with Crohn's disease

Mucosal cytokine expression associated with deep endoscopic mucosal healing in ulcerative colitis

Multiomic features associated with mucosal healing and inflammation in paediatric Crohn's disease

A Noninvasive Method to Assess Mucosal Healing in Patients* With Crohn's Disease

Mucosal Architectural Change is an Important Feature in Distinguishing Crohn's Disease from Others in Terminal Ileum Ulcer Biopsy

Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease

Mucosal Genes Expression in Inflammatory Bowel Disease Patients: New Insights

Non-invasive evaluation of mucosal healing by intestinal ultrasound or fecal calprotectin is efficient in Crohn's disease: A cross-sectional study

Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease

Mucosal healing in inflammatory bowel disease-a true paradigm of success?

CTE-Based Radiomics Models Can Identify Mucosal Healing in Patients with Crohn's Disease

Mucosal host-microbe interactions associate with clinical phenotypes in inflammatory bowel disease

Predictive value of serum markers for mucosal healing in patients with inflammatory bowel disease

Early transmural healing and its predictors assessed by magnetic resonance enterography in patients with Crohn’s disease receiving ustekinumab

Diagnosis of Crohn's disease and ulcerative colitis using the microbiome

Long-term outcomes and associated factors of Crohn's disease patients achieving transmural healing based on magnetic resonance enterography: a Chinese retrospective cohort study

Mucosal microbiome of surgically treated terminal ileal Crohn's disease

Fecal calprotectin and endoscopic scores: The cornerstones in clinical practice for evaluating mucosal healing in inflammatory bowel disease

Factors Associated with Mucosal Healing in Patients with Ulcerative Colitis in Clinical Remission.

The biogeography of the mucosa-associated microbiome in health and disease